Pulse Biosciences (PLSE) Finished Goods (2021 - 2022)
Pulse Biosciences (PLSE) posted Finished Goods of $750000.0 for Q3 2022, down 71.0% on a QoQ basis from $2.6 million in Q2 2022, and down 55.91% year-over-year from $1.7 million in Q3 2021.
Powered by 
Analysis
Pulse Biosciences (PLSE) Finished Goods (2021 - 2022) Analysis & Trends
Pulse Biosciences has reported Finished Goods for 2 years, with the latest figure at $750000.0 in Q3 2022.
- On a quarterly basis, Finished Goods fell 55.91% year-over-year to $750000.0 in Q3 2022; TTM through Sep 2022 was $750000.0, a 55.91% decrease from a year earlier, with the FY2021 full-year figure at $2.4 million, changed N/A from the prior year.
- Finished Goods was $750000.0 for Q3 2022 at Pulse Biosciences, down from $2.6 million in the prior quarter.
- The five-year high for Finished Goods was $2.7 million in Q1 2022, with the low at $750000.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Pulse Biosciences | 3.76 Bn | 3.76 Bn | 161,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 2.74 Mn |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | 1.70 Mn |